Skip to main content
Cheng Liu, MD, Pathology, New York, NY, NYU Langone Hospitals

ChengZLiuMD

Pathology New York, NY

Anatomic Pathology, Clinical Pathology

Professor, Department of Pathology, New York University School of Medicine

Dr. Liu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Liu's full profile

Already have an account?

Summary

  • Dr. Cheng Z. Liu is a pathologist in New York, NY at NYU Langone Hospitals. He received his medical degree from Hubei Medical University and has been in practice 25 years. He specializes in anatomic pathology and clinical pathology.

Education & Training

  • The MetroHealth System/Case Western Reserve University
    The MetroHealth System/Case Western Reserve UniversityResidency, Pathology-Anatomic and Clinical, 1996 - 2000
  • Northwestern university
    Northwestern university Ph.D., Cell and Molecular Pathology , 1990 - 1995
  • Hubei Medical University
    Hubei Medical UniversityClass of 1982

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2014 - 2025
  • WI State Medical License
    WI State Medical License 2013 - 2025
  • OK State Medical License
    OK State Medical License 2001 - 2024
  • American Board of Pathology Anatomic Pathology & Clinical Pathology

Publications & Presentations

PubMed

Press Mentions

  • Eureka Therapeutics Announces New England Journal of Medicine Publication of Clinical Study Demonstrating GPRC5D as an Active Target for the Treatment of Multiple Myeloma
    Eureka Therapeutics Announces New England Journal of Medicine Publication of Clinical Study Demonstrating GPRC5D as an Active Target for the Treatment of Multiple MyelomaSeptember 28th, 2022
  • Eureka Therapeutics Announces Publication of Crystal Structure of TCR Mimic Redirected T Cells Targeting Alpha-Fetoprotein (AFP) for Liver Cancer
    Eureka Therapeutics Announces Publication of Crystal Structure of TCR Mimic Redirected T Cells Targeting Alpha-Fetoprotein (AFP) for Liver CancerAugust 3rd, 2022
  • Eureka Therapeutics Announces Publication of Study Demonstrating Broad Anti-Tumor Activity of TCR Mimic-Redirected T Cells Targeting NDC80
    Eureka Therapeutics Announces Publication of Study Demonstrating Broad Anti-Tumor Activity of TCR Mimic-Redirected T Cells Targeting NDC80June 6th, 2022
  • Join now to see all

Hospital Affiliations